Alberto Papi: has received grants and personal fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici and TEVA
The efficacy of subcutaneous semaglutide was established in the phase III SUSTAIN program (SUSTAIN 15 and 7), in which significant reductions in mean glycated hemoglobin (HbA 1c ) and body weight were demonstrated against placebo and a variety of active comparators in multiple patient groups with T2D [26,27,28,29,30,31,32,33]
We recommend fasting for high-carbohydrate content clear liquids (10% glucose) for 8 h before procedures requiring anaesthesia for patients taking GLP-1 RAs without significant gastrointestinal symptoms (significant symptoms include severe nausea, vomiting, and inability to tolerate oral intake and do not include fullness or early satiety) (C)
Green et al 26 Severe clinical abnormalities should be treated intensively with B 12 , cyanoB 12 or hydroxyB 12 : HydroxyB 12 is commonly used in Europe, often at intervals of 23 months, as it seems to have better retention than cyanoB 12
Scroll to see the comparison
Metabolomics analysis of hormone-responsive and triple-negative breast cancer cell responses to Paclitaxel identify key metabolic differences
